CD3+/CD4+ cells combined with myosteatosis predict the prognosis in patients who underwent gastric cancer surgery.
Zhongze DuYouming XiaoGuiming DengHaibin SongYingwei XueHongjiang SongPublished in: Journal of cachexia, sarcopenia and muscle (2024)
Lymphocyte subsets, including CD3+/CD4+ cells, CD4+/CD8+ ratio and CD19+ cells, are indicative of clinical prognosis in gastric cancer surgery patients. Body composition parameters, such as sarcopenia and myosteatosis, are also associated with the patient's prognosis. The combination of CD3+/CD4+ cells with myosteatosis demonstrates enhanced prognostic value, enabling the identification of patients at high risk of post-operative metastasis and recurrence.
Keyphrases
- induced apoptosis
- body composition
- cell cycle arrest
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- endoplasmic reticulum stress
- prognostic factors
- case report
- coronary artery disease
- resistance training
- cell proliferation
- patient reported outcomes
- acute coronary syndrome
- high intensity
- patient reported